Early research (Phase 1)Study completedNCT00816400
What this trial is testing
A Dose Escalation, Dose Expansion Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575, in Subjects With Advanced Tumors.
Who this might be right for
Cancer
MedImmune LLC 49